-
Huntington’s Disease Community Advocacy Helps Land Critical FDA Meeting for AMT-130
Latest News
-
Liftoff: First humans treated with gene silencing drugs for HD!
Major Announcement: First HD patients treated with gene silencing drugs
-
HDBuzz primer: Clinical trial designs and phases
HDBuzz untangles hope from hype in clinical trial announcements
-
A Few Bad Seeds: Using Brain Fluid to Grow Clumps in Brain Cells
HD brain fluid makes brain cells grow clumps.
-
New tool to measure outcomes in Huntington’s Disease clinical trials
A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain
-
Huge study reveals new 'genetic modifiers' of Huntington's disease
GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset
-
Would ewe believe it? GM1, sheep and Huntington's disease
HD researchers and sheep farmers are collaborating on a brain fat called GM1, but a clinical trial is a long way off
-
Switching it up: variety in the HD gene affects symptom onset
Variety in the HD gene’s on switch affects when symptoms arise.
-
Measuring harmful huntingtin protein in the brain’s bath water
How will we know whether HD-lowering treatments are working? New advancements in the detection of mutant huntingtin.
-
A faulty filter? Blood vessel changes in Huntington's disease
New research reveals blood vessel changes that could contribute to problem in HD
-
Lighting the way: A new biomarker for Huntington’s disease
A new biomarker reveals brain changes in early Huntington's disease.
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
